David Blumenthal, M.D., M.P.P., and Amulya Marellapudi, B.S.
Several U.S. states have enacted or are considering legislation to regulate the use of artificial intelligence (AI) in health care. These bills focus on several key areas: establishing commissions and/or agencies to study and manage health AI; ensuring data privacy and security; addressing bias and discrimination in AI; promoting transparency in AI usage; overseeing claims processing by insurance companies; and training the health care workforce regarding AI. State activities concerning health AI are likely to become more widespread and influential if, as seems likely, the federal government reduces its involvement in ensuring the safety, efficacy, and reliability of health AI applications. A surge in diverse state regulations could impede the AI industry�s efforts to develop and market promising health AI applications. Alternatively, however, producers of AI tools may choose to self-regulate to meet the stringent standards set by states and international authorities, such as the European Union, enabling them to confidently sell their products across all jurisdictions. (Funded by the Commonwealth Fund of New York City.)